Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000139 · ClinicalTrials.gov registry record · Phase 3
Herpetic Eye Disease Study (HEDS) II
A Phase 3 study, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00000139: Completed Phase 3 study, sponsored by National Eye Institute (NEI).
NCT00000139 is a Phase 3 study that has completed, run by National Eye Institute (NEI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000139, a Phase 3 study, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
To determine whether early treatment (with oral acyclovir) of herpes simplex virus (HSV) ulcerations of the corneal epithelium prevents progression to the blinding complications of stromal keratitis and iridocyclitis. To determine the efficacy of low-dose oral acyclovir in preventing recurrent HSV eye infection in patients with previous episodes of herpetic eye disease. To determine the role of external factors (such as ultraviolet light or corneal trauma) and behavioral factors (such as life stress) on the induction of ocular recurrences of HSV eye infections and disease.
Interventions
- DRUG Acyclovir
- BEHAVIORAL Stress
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-10 |
| Phase | Phase 3 |
What the finished NCT00000139 record still lists
NCT00000139 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Acyclovir is the first listed.
NCT00000139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000139 about?
NCT00000139 is a clinical study titled "Herpetic Eye Disease Study (HEDS) II". To determine whether early treatment (with oral acyclovir) of herpes simplex virus (HSV) ulcerations of the corneal epithelium prevents progression to the blinding complications of stromal keratitis and iridocyclitis. To determine the efficacy of low-dose oral acyclovir in preventing recurrent HSV ...
What is the current status of trial NCT00000139?
This trial is currently completed. It is a Phase 3 study. The study started on 1992-10.
What interventions are being tested in trial NCT00000139?
The interventions under investigation include: Acyclovir (DRUG), Stress (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000139?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia